Similarly, it remains unclear why shRNA-mediated knockdown of ZEB1 in the MDA-MB-231 breast cancer cells was correlated with elevated miRNA-200c-3p levels [9] although the MDA-MB-231 cells express ZEB2 too [65,66]. The gene discussed is ZEB2; the disease is breast carcinoma.